PMID: 6162696Mar 1, 1981Paper

Primitive islets contain two populations of cells with differing glucagon immunoreactivity

Diabetes
Y StefanL Orci

Abstract

Immunofluorescence staining with insulin, glucagon, and somatostatin antisera revealed different immunoreactive cell types in the pancreatic islets of the ratfish. In particular, one cell type was present that reacted with C- and N-terminal anti-glucagon sera, while another type was only detected by N-terminal anti-glucagon sera. The latter cell, however, became reactive to C-terminal anti-glucagon after proteolytic treatment of the section. A similar cell type was found in the epithelium of the pancreatic duct and of the gastrointestinal mucosa. The data indicate that among glucagon immunoreactive cells, some cells situated exclusively in the pancreas possess both C- and N-terminal glucagon immunoreactants, while in other pancreatic as well as intestinal cells, the sequence that binds C-terminal anti-glucagon serum appears masked and becomes accessible to the antibody only after proteolytic digestion.

Citations

Dec 10, 2002·Annual Review of Physiology·Tadahiro KitamuraDomenico Accili
Mar 27, 2004·Physiological Reviews·Anindita NandiDomenico Accili
Dec 12, 2001·Endocrine Reviews·J NakaeD Accili
Dec 22, 1999·General and Comparative Endocrinology·J H Youson, A A Al-Mahrouki

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Ductal

Ductal carcinoma is a malignant neoplasm involving the ductal systems of any of a number of organs, such as the mammary glands, pancreas, prostate or lacrimal gland. Discover the latest research on ductal carcinoma here.

American Diabetes Association Journals

Discover the latest diabetes research published by the journals from the American Diabetes Association.